Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2003
10/09/2003CA2480106A1 Morpholinyl-urea derivatives for use of the treatment of inflammatory diseases
10/09/2003CA2479939A1 Immunosuppressant compounds, methods and uses related thereto
10/09/2003CA2479932A1 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
10/09/2003CA2479807A1 Antimicrobial polymer conjugates
10/09/2003CA2479744A1 Substituted 2,3-diphenyl pyridines
10/09/2003CA2479647A1 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog
10/09/2003CA2479618A1 Spirocyclic amides as cannabinoid receptor modulators
10/09/2003CA2479495A1 Remedy for glioblastoma
10/09/2003CA2479205A1 Azaindoles as inhibitors of c-jun n-terminal kinases
10/09/2003CA2478389A1 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/09/2003CA2478017A1 Therapeutic agent for glomerular disease
10/09/2003CA2477764A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003CA2477751A1 Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations
10/09/2003CA2477265A1 Thiazolidine carboxamide derivatives as modulators of the prostaglandin f receptor
10/09/2003CA2476923A1 Method for treating cognitive disorders
10/09/2003CA2448540A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/08/2003EP1350799A2 Inhibitory Immunoglobulin Polypeptides to Human PDGF Beta Receptor
10/08/2003EP1350519A1 Drugs and foods improving the quality of life and process for producing the same
10/08/2003EP1350512A1 Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations
10/08/2003EP1350510A1 Use of agent for suppressing infection and proliferation of human immunodeficiency syndrome virus
10/08/2003EP1350435A2 Compositions and methods for promoting lipid assimilation in pets
10/08/2003EP1349964A2 Method for the prediction of the risk potential for cancerous diseases and inflammatory intestinal diseases and corresponding tests
10/08/2003EP1349962A1 Methods and compositions for detecting polynucleotide duplex damage
10/08/2003EP1349944A2 Latency associated peptide for providing latency to pharmaceutically active proteins
10/08/2003EP1349939A2 Aminoacyl trna synthetases
10/08/2003EP1349932A2 Novel human secreted proteins and polynucleotides encoding the same
10/08/2003EP1349931A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/08/2003EP1349928A2 A novel human g-protein coupled reciptor hgprbmy11 expressed highly in heart and variants thereof
10/08/2003EP1349924A2 Methods and compositions for the diagnosis of cancer susceptibilites and defective dna repair mechanisms and treatment thereof
10/08/2003EP1349918A1 Method of collecting placental stem cells
10/08/2003EP1349873A2 Modulation of il-2- and il-15-mediated t cell responses
10/08/2003EP1349864A2 Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases
10/08/2003EP1349857A1 Purine derivatives as purinergic receptor antagonists
10/08/2003EP1349856A2 Isoindolin-1-one glucokinase activators
10/08/2003EP1349853A2 Antimicrobial quinolone derivatives and use of the same to treat bacterial infections
10/08/2003EP1349852A2 4-(hetero)aryl substituted indolinones
10/08/2003EP1349851A1 Compounds
10/08/2003EP1349850A1 Sodium channel modulators derived from 2-piperidylimidazoles
10/08/2003EP1349847A1 Oxybenzamides derivatives as factor xa inhibitors
10/08/2003EP1349843A1 Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors
10/08/2003EP1349842A1 1-dimercaptoalkylquinazolin-2,4(1h,3h)-diones as matrix metalloproteinase (mmp) inhibitors
10/08/2003EP1349841A2 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
10/08/2003EP1349839A1 Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists
10/08/2003EP1349836A2 Tetracyclic derivatives as spla2 inhibitors
10/08/2003EP1349834A2 Cycloalkyfused [g]-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases
10/08/2003EP1349833A1 Indole and dihydroindole derivatives
10/08/2003EP1349832A2 Substituted benzoindoles as spla2 inhibitors
10/08/2003EP1349830A1 Tetralone derivatives as antitumor agents
10/08/2003EP1349613A2 Thrombopoietin mimetics
10/08/2003EP1349574A2 Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors
10/08/2003EP1349567A1 Compositions containing gangliosides for use in the treatment of skin disorders
10/08/2003EP1349559A1 Compositions for inducing secretion of insulin-like growth factor-1
10/08/2003EP1349558A1 Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity
10/08/2003EP1349549A2 Novel medicament compositions based on anticholinesterase drugs and on ciclesonides
10/08/2003EP1349548A2 Methods and compositions for treating periodontal disease
10/08/2003EP1349546A2 Dissociated glucocorticoid receptor antagonists for the treatment of clucocorticoid associated side-effect
10/08/2003EP1227808B1 Use of treosulfan for patient conditioning before bone marrow or blood stem cell transplantation
10/08/2003EP1214318B1 Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives
10/08/2003EP1183014B1 Controlled release and taste masking oral pharmaceutical compositions
10/08/2003EP1181285B1 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides
10/08/2003EP1144421B1 Phosphinic pseudopeptides inhibitors of matrix metalloproteases
10/08/2003EP1140934B1 Benzisoxazoles and phenones as alpha-2-antagonists
10/08/2003EP1105377B1 Pyrimidinone derivatives for the treatment of atherosclerosis
10/08/2003EP1100530B1 In-vitro stimulation of beta cell proliferation
10/08/2003EP1070068B1 Granulatimide derivatives for use in cancer treatment
10/08/2003EP1001935B1 Indole derivatives as mcp-1 receptor antagonists
10/08/2003EP0946512B1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors
10/08/2003EP0929299B1 SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINES AND 2-AMINOCYCLOHEPTA(b)BENZOFURANS
10/08/2003EP0927170B1 Piperazino derivatives as neurokinin antagonists
10/08/2003EP0882707B1 Novel tricyclic compounds and drug compositions containing the same
10/08/2003EP0865448B1 Apoptosis induced by monoclonal antibody anti-her2
10/08/2003EP0812319B9 2-arylbenzazole compounds
10/08/2003EP0750628B1 Fibroblast growth factor-10
10/08/2003EP0670898B1 Interleukin-3 (il-3) mutant polypeptides
10/08/2003EP0533845B1 USING 5,10,15,20-TETRAKIS(r-CARBOXYPHENYL)PORPHINE FOR DETECTING AND TREATING LUNG CANCER
10/08/2003CN1447920A Compsns. and methods for modulating tumor specific expression
10/08/2003CN1447819A Human CYR 61
10/08/2003CN1447811A Medicinal compsns. and its use
10/08/2003CN1447810A Bicyclo-pyrazoles active as kinase inhibitors,process for their prepn. and pharmaceutical compsns. comprising them
10/08/2003CN1447808A Oxazolidinone derivatives as anticrobials
10/08/2003CN1447807A Chromenone derivatives and their use for treating diseases in conjunction with 5-HT1A receptors and/or dopamine D2 receptors
10/08/2003CN1447804A 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders
10/08/2003CN1447799A Giphenyl derivatives and use thereof as integrin inhibitors
10/08/2003CN1447795A Biphenyl derivatives and use thereof as integrin inhibitors
10/08/2003CN1447794A Novel compounds
10/08/2003CN1447793A Prodrugs to NMDA receptor ligands
10/08/2003CN1447777A Method and appts. for preparing aqueous dispersion of ultra-fine active carbon particles
10/08/2003CN1447699A Peptide and peptide minetic conjugates with integrin-inhibitor properties
10/08/2003CN1447697A Antitumor effect potentiators
10/08/2003CN1447696A Gene detection assay for improving likelihood of effective response to erbb antagonist cancer therapy
10/08/2003CN1447693A Use of angiotensin Ôàí antagonists
10/08/2003CN1447691A Pharmaceutical combination of angiotensin Ôàí antagonists and ace inhibitors
10/08/2003CN1447690A Inhibition of cystic fibrosis transmembrane conductance regulator chloride channel
10/08/2003CN1447686A D-Enantiomer of DFMO and methods of use thereof for treating cancer
10/08/2003CN1447685A Process for decreasing cell proliferation based on (3R,4R)-Ôû�8-tetrahydrocannabinol)-11-acid
10/08/2003CN1446813A Novel dihydric indole compound, their prepn. process and medicinal compsns. contg.them
10/08/2003CN1446580A Preparation of effective component from rhodiola crenulate
10/08/2003CN1446573A Per oral health products for blacking hairs and pilatory effect
10/08/2003CN1123573C 2-phenyl substituted imidazotrizainones as phosphodiesterase inhibitors
10/08/2003CN1123571C 1-(3-heteroarylpropyl-or-prop-2-enyl)-4-benzylpiperidines used as NMDA receptor antagonists
1 ... 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 ... 1564